|
EXP002201
|
Cellular delivery of a double-stranded oligonucleotide NFκB decoy by hybridizat…
|
2004 |
Transportan-10 (TP10)
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP002202
|
Multistage pH-responsive codelivery liposomal platform for synergistic cancer t…
|
2022 |
DPRP (dual pH-responsive peptide)
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002203
|
Multistage pH-responsive codelivery liposomal platform for synergistic cancer t…
|
2022 |
DPRP (dual pH-responsive peptide)
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002204
|
Lipoprotein-biomimetic nanostructure enables tumor-targeted penetration deliver…
|
2022 |
D4F
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002205
|
Lipoprotein-biomimetic nanostructure enables tumor-targeted penetration deliver…
|
2022 |
D4F
|
siRNA
|
yes |
|
|
yes |
no |
|
EXP002206
|
Lipoprotein-biomimetic nanostructure enables tumor-targeted penetration deliver…
|
2022 |
tLyP-1
|
siRNA
|
no |
|
|
no |
no |
|
EXP002207
|
Lipoprotein-biomimetic nanostructure enables tumor-targeted penetration deliver…
|
2022 |
tLyP-1-D4F
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002208
|
Lipoprotein-biomimetic nanostructure enables tumor-targeted penetration deliver…
|
2022 |
tLyP-1-D4F
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002209
|
Functionalized DMP-039 Hybrid Nanoparticle as a Novel mRNA Vector for Efficient…
|
2021 |
cRGD-R9
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP002210
|
Functionalized DMP-039 Hybrid Nanoparticle as a Novel mRNA Vector for Efficient…
|
2021 |
cRGD-R9
|
mRNA
|
yes |
|
|
yes |
yes |
|
EXP002211
|
Cyclic Peptide-Capped Gold Nanoparticles for Enhanced siRNA Delivery
|
2014 |
WR5
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002212
|
A cell-penetrating peptide enhances delivery and efficacy of phosphorodiamidate…
|
2022 |
RC-1001 CPP (proprietary)
|
ASO
|
no |
|
|
yes |
yes |
|
EXP002213
|
Blockade of HIF-1α and STAT3 by hyaluronate-conjugated TAT-chitosan-SPION nanop…
|
2021 |
HIV-Tat
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002214
|
Blockade of HIF-1α and STAT3 by hyaluronate-conjugated TAT-chitosan-SPION nanop…
|
2021 |
HIV-Tat
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002215
|
Antisense peptide nucleic acids against ftsZ and efaA genes inhibit growth and …
|
2020 |
(RXR)4 carrier peptide
|
ASO
|
no |
yes |
|
no |
no |
|
EXP002216
|
A non-covalent strategy combining cationic lipids and CPPs to enhance delivery …
|
2010 |
S413-PV
|
oligonucleotide
|
yes |
yes |
|
no |
no |
|
EXP002217
|
A non-covalent strategy combining cationic lipids and CPPs to enhance delivery …
|
2010 |
Reverse NLS
|
oligonucleotide
|
yes |
yes |
|
no |
no |
|
EXP002218
|
A non-covalent strategy combining cationic lipids and CPPs to enhance delivery …
|
2010 |
Scrambled S413-PV
|
oligonucleotide
|
yes |
yes |
|
no |
no |
|
EXP002219
|
A non-covalent strategy combining cationic lipids and CPPs to enhance delivery …
|
2010 |
Tat
|
oligonucleotide
|
yes |
yes |
|
no |
no |
|
EXP002220
|
In Vivo Delivery of siRNAs Targeting EGFR and BRD4 Expression by Peptide-Modifi…
|
2021 |
GALA
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002221
|
In Vivo Delivery of siRNAs Targeting EGFR and BRD4 Expression by Peptide-Modifi…
|
2021 |
GALA
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002222
|
In Vivo Delivery of siRNAs Targeting EGFR and BRD4 Expression by Peptide-Modifi…
|
2021 |
CREKA
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002223
|
In Vivo Delivery of siRNAs Targeting EGFR and BRD4 Expression by Peptide-Modifi…
|
2021 |
CREKA
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002224
|
Targeting Listeria monocytogenes rpoA and rpoD genes using peptide nucleic acids
|
2013 |
anti-rpoA (KFF)3K-PNA
|
ASO
|
no |
yes |
|
no |
no |
|
EXP002225
|
Targeting Listeria monocytogenes rpoA and rpoD genes using peptide nucleic acids
|
2013 |
anti-rpoA (KFF)3K-PNA
|
ASO
|
no |
|
|
yes |
yes |
|
EXP002226
|
Targeting Listeria monocytogenes rpoA and rpoD genes using peptide nucleic acids
|
2013 |
anti-rpoD (KFF)3K-PNA
|
ASO
|
no |
yes |
|
no |
no |
|
EXP002227
|
Targeting Listeria monocytogenes rpoA and rpoD genes using peptide nucleic acids
|
2013 |
anti-rpoD (KFF)3K-PNA
|
ASO
|
no |
|
|
yes |
no |
|
EXP002228
|
Targeting Listeria monocytogenes rpoA and rpoD genes using peptide nucleic acids
|
2013 |
control (KFF)3K-PNA
|
ASO
|
no |
yes |
|
no |
no |
|
EXP002229
|
Bacterial outer membrane vesicle nanorobot
|
2024 |
CPP (ClyA-CPP fusion)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002230
|
Bacterial outer membrane vesicle nanorobot
|
2024 |
CPP (ClyA-CPP fusion)
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002231
|
Bioengineered Extracellular Membranous Nanovesicles for Efficient Small-Interfe…
|
2016 |
RGD
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002232
|
Bioengineered Extracellular Membranous Nanovesicles for Efficient Small-Interfe…
|
2016 |
RGD
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002233
|
Transportan-derived cell-penetrating peptide delivers siRNA to inhibit replicat…
|
2019 |
T9(dR)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002234
|
Transportan-derived cell-penetrating peptide delivers siRNA to inhibit replicat…
|
2019 |
T9(dR)
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP002235
|
Immobilization of HIV‐1 TAT peptide on gold nanoparticles: A feasible approach …
|
2020 |
HIV-1 TAT CPP
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002236
|
Protein and siRNA delivery by transportan and transportan 10 into colorectal ca…
|
2014 |
TP
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002237
|
Protein and siRNA delivery by transportan and transportan 10 into colorectal ca…
|
2014 |
TP-biot1
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002238
|
Protein and siRNA delivery by transportan and transportan 10 into colorectal ca…
|
2014 |
TP-biot13
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002239
|
Protein and siRNA delivery by transportan and transportan 10 into colorectal ca…
|
2014 |
TP10
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002240
|
Protein and siRNA delivery by transportan and transportan 10 into colorectal ca…
|
2014 |
TP10-biot1
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002241
|
Enzyme-sensitive nanoparticles, smart TAT and cetuximab conjugated immunoliposo…
|
2022 |
TAT
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002242
|
Enzyme-sensitive nanoparticles, smart TAT and cetuximab conjugated immunoliposo…
|
2022 |
MMP2 substrate
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002243
|
Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino…
|
2021 |
(RXR)4 CPP
|
oligonucleotide
|
no |
no |
|
no |
no |
|
EXP002244
|
Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino…
|
2021 |
(RXR)4 CPP
|
oligonucleotide
|
no |
yes |
|
no |
no |
|
EXP002245
|
Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino…
|
2021 |
(RXR)4 CPP
|
oligonucleotide
|
no |
yes |
|
no |
no |
|
EXP002246
|
Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino…
|
2021 |
(RXR)4 CPP
|
oligonucleotide
|
no |
yes |
|
no |
no |
|
EXP002247
|
Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino…
|
2021 |
(RXR)4 CPP
|
oligonucleotide
|
no |
yes |
|
no |
no |
|
EXP002248
|
Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino…
|
2021 |
(RXR)4 CPP
|
oligonucleotide
|
no |
yes |
|
no |
no |
|
EXP002249
|
Treatment of Melanoma by Nano-conjugate-Delivered Wee1 siRNA
|
2021 |
R8–cRGD CPP
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002250
|
Treatment of Melanoma by Nano-conjugate-Delivered Wee1 siRNA
|
2021 |
R8–cRGD CPP
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP002251
|
Nanogels Enable Efficient miRNA Delivery and Target Gene Downregulation in Tran…
|
2019 |
HIV-1 TAT
|
miRNA
|
yes |
yes |
|
no |
no |
|
EXP002252
|
Nanogels Enable Efficient miRNA Delivery and Target Gene Downregulation in Tran…
|
2019 |
HIV-1 TAT
|
miRNA
|
yes |
yes |
|
no |
no |
|
EXP002253
|
Nanogels Enable Efficient miRNA Delivery and Target Gene Downregulation in Tran…
|
2019 |
HIV-1 TAT
|
miRNA
|
yes |
yes |
|
no |
no |
|
EXP002254
|
Tumor-Penetrating Delivery of siRNA against TNFα to Human Vestibular Schwannomas
|
2017 |
myristoyl-TP-iRGD
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002255
|
Tumor-Penetrating Delivery of siRNA against TNFα to Human Vestibular Schwannomas
|
2017 |
myristoyl-TP-iRGE (scrambled control)
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002256
|
Co-Polymer Carrier with Dual Advantages of Cartilage-Penetrating and Targeting …
|
2022 |
CAP (cartilage-targeting peptide)
|
miRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002257
|
Co-Polymer Carrier with Dual Advantages of Cartilage-Penetrating and Targeting …
|
2022 |
CAP (cartilage-targeting peptide)
|
miRNA
|
no |
|
|
yes |
yes |
|
EXP002258
|
Modularized Gold Nanocarriers for TAT-Mediated Delivery of siRNA
|
2016 |
TAT
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002259
|
The promoted delivery of RRM2 siRNA to vascular smooth muscle cells through lip…
|
2018 |
CyLoP-1 (CCPs)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002260
|
A cell-penetrating phospholamban-specific RNA aptamer enhances Ca2+ transients …
|
2014 |
modified TAT (mTAT)
|
aptamer
|
yes |
yes |
|
no |
no |
|
EXP002261
|
Effect of HIV-1 TAT Peptide Fusion on 5′ mRNA Cap Analogs Cell Membrane Permeab…
|
2020 |
HIV-1 TAT
|
oligonucleotide
|
yes |
yes |
|
no |
no |
|
EXP002262
|
Effect of HIV-1 TAT Peptide Fusion on 5′ mRNA Cap Analogs Cell Membrane Permeab…
|
2020 |
HIV-1 TAT
|
oligonucleotide
|
yes |
yes |
|
no |
no |
|
EXP002263
|
Synthesis and Studies on Cell-Penetrating Peptides
|
2009 |
Peptide 1
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP002264
|
Synthesis and Studies on Cell-Penetrating Peptides
|
2009 |
Peptide 1a
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP002265
|
Synthesis and Studies on Cell-Penetrating Peptides
|
2009 |
Peptide 2
|
ASO
|
yes |
no |
|
no |
no |
|
EXP002266
|
Synthesis and Studies on Cell-Penetrating Peptides
|
2009 |
Peptide 2a
|
ASO
|
yes |
no |
|
no |
no |
|
EXP002267
|
Synthesis and Studies on Cell-Penetrating Peptides
|
2009 |
Peptide 3
|
ASO
|
yes |
no |
|
no |
no |
|
EXP002268
|
Synthesis and Studies on Cell-Penetrating Peptides
|
2009 |
Peptide 3a
|
ASO
|
yes |
no |
|
no |
no |
|
EXP002269
|
Synthesis and Studies on Cell-Penetrating Peptides
|
2009 |
Peptide 4
|
ASO
|
yes |
no |
|
no |
no |
|
EXP002270
|
Synthesis and Studies on Cell-Penetrating Peptides
|
2009 |
Peptide 4a
|
ASO
|
yes |
no |
|
no |
no |
|
EXP002271
|
Synthesis and Studies on Cell-Penetrating Peptides
|
2009 |
Peptide 5
|
ASO
|
yes |
no |
|
no |
no |
|
EXP002272
|
Synthesis and Studies on Cell-Penetrating Peptides
|
2009 |
Peptide 5a
|
ASO
|
yes |
no |
|
no |
no |
|
EXP002273
|
Synthesis and Studies on Cell-Penetrating Peptides
|
2009 |
Peptide 6
|
ASO
|
yes |
no |
|
no |
no |
|
EXP002274
|
Synthesis and Studies on Cell-Penetrating Peptides
|
2009 |
Peptide 6a
|
ASO
|
yes |
no |
|
no |
no |
|
EXP002275
|
Targeting Cytokine Expression in Glial Cells by Cellular Delivery of an NF-κB D…
|
2007 |
Transportan-10 (TP10)
|
oligonucleotide
|
yes |
yes |
|
no |
no |
|
EXP002276
|
Targeting Cytokine Expression in Glial Cells by Cellular Delivery of an NF-κB D…
|
2007 |
Cys-PNA 9-mer
|
oligonucleotide
|
no |
no |
|
no |
no |
|
EXP002277
|
DG9-conjugated morpholino rescues phenotype in SMA mice by reaching the CNS via…
|
2023 |
DG9
|
SCO
|
yes |
|
|
yes |
yes |
|
EXP002278
|
DG9-conjugated morpholino rescues phenotype in SMA mice by reaching the CNS via…
|
2023 |
DG9
|
SCO
|
yes |
|
|
yes |
yes |
|
EXP002279
|
DG9-conjugated morpholino rescues phenotype in SMA mice by reaching the CNS via…
|
2023 |
R6G
|
SCO
|
no |
|
|
yes |
yes |
|
EXP002280
|
Delivery of siRNA Using Functionalized Gold Nanorods Enhances Anti-Osteosarcoma…
|
2021 |
CPP-Pep-TH
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002281
|
Delivery of siRNA Using Functionalized Gold Nanorods Enhances Anti-Osteosarcoma…
|
2021 |
CPP-Pep-TH
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002282
|
RNase non-sensitive and endocytosis independent siRNA delivery system
|
2013 |
CPP-SWCNT
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002283
|
Protein Expression Correlates Linearly with mRNA Dose over Up to Five Orders of…
|
2021 |
Pepfect14
|
mRNA
|
yes |
yes |
no |
no |
no |
|
EXP002284
|
Multifunctional elastin-like polypeptide nanocarriers for efficient miRNA deliv…
|
2024 |
Tat-A86
|
miRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002285
|
Multifunctional elastin-like polypeptide nanocarriers for efficient miRNA deliv…
|
2024 |
Tat-A86
|
miRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002286
|
Development of non-viral vectors for neuronal-targeted delivery of CRISPR-Cas9 …
|
2022 |
C2-PepFect14
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002287
|
In Vivo Follow-Up of Gene Inhibition in Solid Tumors Using Peptide-Based Nanopa…
|
2021 |
WRAP5
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002288
|
In Vivo Follow-Up of Gene Inhibition in Solid Tumors Using Peptide-Based Nanopa…
|
2021 |
WRAP5
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002289
|
Chemical conjugation of an mRNA cap analogue with a cell-penetrating peptide as…
|
2014 |
MPS
|
mRNA
|
no |
|
|
no |
no |
|
EXP002290
|
Immortalized Canine Dystrophic Myoblast Cell Lines for Development of Peptide-C…
|
2021 |
Pip8b2
|
SCO
|
yes |
yes |
yes |
no |
no |
|
EXP002291
|
EGFP-Based Protein Nanoparticles with Cell-Penetrating Peptide for Efficient si…
|
2015 |
H6-TatEGFP
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002292
|
Carrier PNA for shRNA delivery into cells
|
2009 |
Carrier-PNA-R8
|
shRNA
|
yes |
yes |
no |
no |
no |
|
EXP002293
|
Role of nuclear localization signals in the DNA delivery function of Chikunguny…
|
2021 |
NLS1
|
pDNA
|
yes |
yes |
|
no |
no |
|
EXP002294
|
Role of nuclear localization signals in the DNA delivery function of Chikunguny…
|
2021 |
NLS2
|
pDNA
|
no |
no |
|
no |
no |
|
EXP002295
|
Macrophage membrane-reversibly camouflaged nanotherapeutics accelerate fracture…
|
2024 |
PG (α-helical polypeptide)
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002296
|
Macrophage membrane-reversibly camouflaged nanotherapeutics accelerate fracture…
|
2024 |
PG (α-helical polypeptide)
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002297
|
Tumor Cell Lysate-Based Multifunctional Nanoparticles Facilitate Enhanced mRNA …
|
2024 |
TAT-iRGD
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP002298
|
Tumor Cell Lysate-Based Multifunctional Nanoparticles Facilitate Enhanced mRNA …
|
2024 |
TAT-iRGD
|
mRNA
|
yes |
|
|
yes |
yes |
|
EXP002299
|
TAT decorated siRNA polyplexes for inhalation delivery in anti-asthma therapy
|
2023 |
HIV-1 TAT(47–57)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002300
|
Novel peptide (RATH) mediated delivery of peptide nucleic acids for antiviral i…
|
2021 |
RATH
|
ASO
|
yes |
yes |
|
no |
no |